Insider · CIK 0001543174

TANNENBAUM RENEE P

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001543174

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director	AAward	+40.6K sh	—	—	209,331
2026-05-21	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+4,357 sh	—	—	29,514
2025-12-05	ANIPANI PHARMACEUTICALS INCS Sale	Director	SSale	−1,800 sh	$81.15	−$146K	25,157
2025-06-26	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director	AAward	+40.6K sh	—	—	168,766
2025-05-22	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+4,336 sh	—	—	26,957
2024-12-12	CRDFCardiff Oncology, Inc.P Purchase	Director	PPurchase	+10K sh	$3.42	+$34.2K	20,000
2024-06-27	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director	AAward	+29.7K sh	—	—	128,201
2024-05-21	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+4,410 sh	—	—	22,621
2024-05-16	ANIPANI PHARMACEUTICALS INCS Sale	Director	SSale	−2,000 sh	$63.87	−$128K	18,211
2023-06-15	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director	AAward	+27.7K sh	—	—	98,501
2023-05-23	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+6,865 sh	—	—	20,211
2022-09-15	CRDFCardiff Oncology, Inc.P Purchase	Director	PPurchase	+6,400 sh	$1.72	+$11K	6,400
2022-09-15	CRDFCardiff Oncology, Inc.P Purchase	Director	PPurchase	+3,600 sh	$1.72	+$6,192	10,000
2022-03-19	ANIPANI PHARMACEUTICALS INCA Award	Director	AAward	+13.3K sh	—	—	13,346
2022-03-09	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director	AAward	+26.8K sh	—	—	70,801
2022-03-07	ZOGENIX, INC.U Disposition from Tender	Director	UDisposition from Tender	−32.6K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,000 sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2021-11-29	ZOGENIX, INC.S Sale	Director	SSale	−5,305 sh	$11.72	−$62.2K	32,567
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director	AAward	+44K sh	—	—	44,001
2021-06-01	ZOGENIX, INC.P Purchase	Director	PPurchase	+5,000 sh	$17.05	+$85.2K	37,872
2021-05-27	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2020-11-17	ZOGENIX, INC.S Sale	Director	SSale	−15K sh	$20.74	−$311K	32,872
2020-05-29	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-05-22	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-03-06	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,375 sh	$10.40	+$97.5K	19,375
2019-03-06	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$12.80	+$76.8K	25,375
2019-03-06	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$12.75	+$255K	45,375
2019-03-06	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$8.99	+$180K	65,375
2019-03-06	ZOGENIX, INC.S Sale	Director	SSale	−17.5K sh	$50.65	−$886K	47,872
2019-03-06	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,375 sh	—	—	0
2019-03-06	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	3,000
2019-03-06	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2019-03-06	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2018-05-23	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-05-23	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-03-16	ZOGENIX, INC.P Purchase	Director	PPurchase	+5,000 sh	$11.00	+$55K	10,000
2016-07-13	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2015-12-03	ZOGENIX, INC.P Purchase	Director	PPurchase	+5,000 sh	$15.40	+$77K	5,000
2015-06-18	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+72K sh	—	—	72,000
2015-02-06	ZOGENIX, INC.Right to buy common stockA Award	Director	AAward	+75K sh	—	—	75,000
2013-11-21	SHARPS COMPLIANCE CORPA Award	Director	AAward	+11.2K sh	—	—	40,932
2012-11-15	SHARPS COMPLIANCE CORPA Award	Director	AAward	+11.2K sh	—	—	29,684
2012-03-16	SHARPS COMPLIANCE CORPP Purchase	Director	PPurchase	+2,300 sh	$3.85	+$8,855	10,736
2012-03-16	SHARPS COMPLIANCE CORPP Purchase	Director	PPurchase	+7,700 sh	$3.83	+$29.5K	18,436

Recent filings

Accepted (ET)
Jun 154
TANNENBAUM RENEE P0001543174-26-000005
SEC(opens sec.gov)
Jun 104
TANNENBAUM RENEE P0001543174-26-000003
SEC(opens sec.gov)
Dec 94
TANNENBAUM RENEE P0001543174-25-000006
SEC(opens sec.gov)
Jun 304
TANNENBAUM RENEE P0001641172-25-017072
SEC(opens sec.gov)
May 274
TANNENBAUM RENEE P0001543174-25-000002
SEC(opens sec.gov)
Dec 164
TANNENBAUM RENEE P0000950170-24-136725
SEC(opens sec.gov)
Jul 14
TANNENBAUM RENEE P0001628280-24-030642
SEC(opens sec.gov)
May 234
TANNENBAUM RENEE P0001543174-24-000005
SEC(opens sec.gov)
May 174
TANNENBAUM RENEE P0001543174-24-000002
SEC(opens sec.gov)
Jun 204
TANNENBAUM RENEE P0001628280-23-022731
SEC(opens sec.gov)
May 244
TANNENBAUM RENEE P0001104659-23-064160
SEC(opens sec.gov)
Sep 194
TANNENBAUM RENEE P0001628280-22-025101
SEC(opens sec.gov)
Mar 224
TANNENBAUM RENEE P0001415889-22-003266
SEC(opens sec.gov)
Mar 104
TANNENBAUM RENEE P0001628280-22-005796
SEC(opens sec.gov)
Mar 94
TANNENBAUM RENEE P0000899243-22-010303
SEC(opens sec.gov)
Nov 304
TANNENBAUM RENEE P0001375151-21-000102
SEC(opens sec.gov)
Jun 144
TANNENBAUM RENEE P0001628280-21-012177
SEC(opens sec.gov)

Companies

Address

11055 FLINTKOTE AVENUE C/O CARDIFF ONCOLOGY, INC.

SAN DIEGO, CA, 92121